Alkermes ALKS
NASDAQ ALKS
$45.40 -0.09 (-0.20%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alkermes (ALKS) Change in Acquisitions & Divestments (2010 - 2026)

Alkermes' (ALKS) quarterly Change in Acquisitions & Divestments came in at $20.1 million in Q2 2026, down 75.38% year-over-year from $81.6 million in Q2 2025, and down 52.86% quarter-over-quarter from $42.6 million in Q1 2026.

Analysis

Alkermes (ALKS) Change in Acquisitions & Divestments (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Change in Acquisitions & Divestments for 17 consecutive years, with $20.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Change in Acquisitions & Divestments fell 75.38% year-over-year to $20.1 million in Q2 2026; TTM through Jun 2026 was $565.1 million, a 54.23% increase from a year earlier, with the FY2025 full-year figure at $697.5 million, up 124.79% from the prior year.
  • Change in Acquisitions & Divestments was $20.1 million for Q2 2026 at Alkermes, down from $42.6 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $377.1 million in Q4 2025 and troughed at $20.1 million in Q2 2026.
  • A 5-year average of $94.9 million and a median of $82.0 million in 2024 frame the typical range for Change in Acquisitions & Divestments.
  • Across the five-year window, Change in Acquisitions & Divestments surged 341.06% in 2025 and tumbled 75.38% in 2026, its largest moves.
  • Over 5 years, Change in Acquisitions & Divestments stood at $90.6 million in 2022, then slipped by 29.85% to $63.6 million in 2023, then jumped by 34.48% to $85.5 million in 2024, then soared by 341.06% to $377.1 million in 2025, then slumped by 94.67% to $20.1 million in 2026.
  • The last three Change in Acquisitions & Divestments figures came in at $20.1 million (Q2 2026), $42.6 million (Q1 2026), and $377.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn -
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn
10 Alkermes 7.58 Bn 6.92 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20.09 Mn
Mar 31, 2026 42.61 Mn
Dec 31, 2025 377.11 Mn
Sep 30, 2025 125.31 Mn
Jun 30, 2025 81.59 Mn
Mar 31, 2025 113.49 Mn
Dec 31, 2024 85.50 Mn
Sep 30, 2024 85.84 Mn
Jun 30, 2024 56.46 Mn
Mar 31, 2024 82.49 Mn
Dec 31, 2023 63.58 Mn
Sep 30, 2023 51.40 Mn
Jun 30, 2023 136.94 Mn
Mar 31, 2023 103.61 Mn
Dec 31, 2022 90.63 Mn
Sep 30, 2022 81.07 Mn
Jun 30, 2022 49.15 Mn
Mar 31, 2022 60.78 Mn
Dec 31, 2021 53.93 Mn
Sep 30, 2021 65.58 Mn